No Detail Found!

Individualised Medicine: Application of a Personalised Approach in Clinical Practice

Author(s)
Dmytro Maltsev Head of Immunology and Molecular Biology Laboratory, Institute of Experimental and Clinical Medicine, O. Bogomolets National Medical University, Kyiv, Ukraine
Yuliya Tyravska Department of Internal Medicine No. 4, Medical Faculty No. 3, Bogomolets National Medical University, Kyiv, Ukraine
Yaroslav Shpryakha Department of Surgical Diseases, Faculty of Medicine, Uzhhorod National University, Uzhhorod, Ukraine
Valery Kaminskyy Department of Maxillo-Facial Surgery, Shupyk National University of Health Care of Ukraine, Kyiv, Ukraine
Serhii Merzliak Department of Oncology and Oncological Surgery, Zaporizhia State Medical and Pharmaceutical University, Zaporizhzhia, Ukraine
Abstract
Introduction: The adoption of individualized medicine in clinical practice has multifaceted challenges and advantages. The aim is to strategically address these challenges for better outcomes by focusing on specific needs of treatment, patient evaluation and adoption issues. Method: A systematic review was conducted from 2020 to 2025 to assess the clinical application of personalized medicine through rigorous keyword searches in Scopus. 16 relevant randomized control trials studies were identified using strict inclusion/exclusion criteria and all were evaluated for risk of bias and study quality. Result: This systematic review assesses the approaches to personalized medicine of 16 RCTs conducted in different countries (Germany, China, UK, US, France and Japan) and various biomarkers into the management of depression, cancer and cardiovascular diseases. Personalized therapies showed significantly greater response rates, ranging from 48.7% to 87% and lower or no adverse drug reactions. These therapies included pharmacogenomic-guided antidepressant therapy, personalized dietary management and targeted therapies for cancer. Conclusion: Clinical outcomes are enhanced across a range of diseases due to the increased response rates and lower adverse reactions associated with treating patients using genetic, pharmacogenomic and biomarker-driven methodologies when compared to traditional methods.
Publication Details
Page(s) 7-19
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Clinical outcomes, Precision medicine, Genetic Diagnostics, Patient-Specific Treatment, Healthcare Optimization
References
Is Personalized Medicine What .2025 .com/what-is-personalizedmedicine-and-why-is-it-important/ (accessed April 5,. , : .
Vicente A.M.,Ballensiefen W.,Jönsson J.I.,April J.I. .2020 .How personalised medicine will transform healthcare by 2030: the ICPerMed vision. ” Journal of Translational Medicine, 18(1) : .
Brunak ,July .2020 .Towards standardization guidelines for in silico approaches in personalized medicine. ” Journal of Integrative Bioinformatics, 17(2) : .
.2025 .-medicine-concepts-application-benefits-andchallenges.. application, benefits and challenges, : .
Radziievska .2081 .Modern achievements and prospects for the development of higher medical education: Ukrainian realities. ” Amazonia Investiga, 11(55) : 114-123.
Tsekhmister . .Virtual reality in EU healthcare: empowering patients and enhancing rehabilitation. ” Journal of Biochemical Technology, 14(2023) : 23-29.
Ho ,Dean .2020 .Enabling technologies for personalized and precision medicine. ” Trends in Biotechnology, 7799(19) : 30316-6.
Number Analytics .2025 .-personalizedmedicine-healthcare-pharma.. Future of personalized medicine in healthcare & pharma Number Analytics Blog, : .
Goetz ,Nicholas J.,Schork J. . .Personalized medicine: motivation, challenges, and progress. ” Fertility and Sterility, 109(6) : 952-963.
Cinti .2024 .The roadmap toward personalized medicine: Challenges and opportunities. ” Journal of Personalized Medicine, 14(6) : .
. .ScienceDaily, Quest for personalized medicine hits a snag 2024. , : .
Wang ,Tao .2023 .Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. ” BMJ Open, 13(1) : .
Badr ,April .2024 .The use of big data in personalized healthcare to reduce inventory waste and optimize patient treatment. ” Journal of Personalized Medicine, 14(4) : .
Fauci H. Clifford,Lane H. Clifford,July H. Clifford .2020 .Four decades of HIV/AIDS-much accomplished, much to do. New England Journal of Medicine, 383(1) : .
Kumbale Carla M.,Voit and Eberhard O.,July and Eberhard O. .2021 .Toward personalized medicine for HIV/AIDS. Journal of AIDS and HIV Treatment, 3(2) : .
Ahmed .2023 .Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review. ” Frontiers in Medicine, 10 : .
Boudi ,Ava L .2024 .-challengesof-artificial-intelligence-in-medicine. pdf., 16(11) : .
Maier Hannah,Benedictine Hannah,April Hannah .2024 .Validation of the predictive value of BDNF-87 methylation for antidepressant treatment success in severely depressed patients-a randomized raterblinded trial. ” Trials, 25(1) : .
Kang .2023 .Multigenetic PharmacogenomicsGuided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial.” JAMA Network Open. , 6(10) : .
Pan ,March .2024 .Smoking and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: A substudy from the randomized PATH‐PCI trial. ” Clinical Cardiology, 47(3) : .
Heald ,April 2024 . .Enhancing type 2 diabetes treatment through digital plans of care-a randomized controlled trial: evaluation of change in patient reported outcome measures. ” Expert Review of Endocrinology & Metabolism, 19(4) : 385-391.
Infeld . .Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial. ” JAMA Cardiology, 8(2023) : 213-221.
Barlesi .2022 .Comprehensive genome profiling in patients with metastatic non-small cell lung cancer: The precision medicine phase II randomized SAFIR02-Lung Trial. Clinical Cancer Research, 28(18) : 4018-4026.
Noguchi .2020 .A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel. com/10, 7847(2021) : 159-168.
Brglez .2020 .Personalized medicine for PLA2R1- related membranous nephropathy: A multicenter randomized control trial. ” Frontiers in Medicine, 0041 : .
.2025 .. -market-report., : .
Nakhod .2024 .Advances in molecular and genetic technologies and the problems related to their application in personalized medicine. ” Journal of Personalized Medicine, 14(6) : .
Personalized Medicine Global .2024 .-biomarkers-market-global.. , : 2019.
Serelli-Lee ,April .2022 .A state-of-the-art roadmap for biomarker-driven drug development in the era of personalized therapies. ” Journal of Personalized Medicine, 12(5) : .
.2020 .CORDIS - EU research results. PERsonalised medicIne, 10 : .
Zhang .2095 .Designing and analyzing clinical trials for personalized medicine via Bayesian models. , 20(3) : 573-596.
'Connor O .2024 .Personalized medicine: when the common becomes the rare. , 11 : .
Jain ,November 2022 . .Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements. EPMA Journal, 13(4) : 561-580.
Yamamoto ,March .2022 .Current status, issues and future prospects of personalized medicine for each disease. ” Journal of Personalized Medicine, 12(3) : .
Pandey .2024 .(A Comprehensive Review). ” Oriental Journal Of Chemistry, 40(4) : .
Abul-Husn Eimear E. Kenny. . .Personalized medicine and the power of electronic health records. ” Cell, 8674(19) : 30222-3.
Su ,March .2024 .Personalized drug therapy: innovative concept guided with proteoformics. ” Molecular & Cellular Proteomics, 9476(24) : 00027-6.
Micaglio .2021 .Role of pharmacogenetics in adverse drug reactions: an update towards personalized medicine. ” Frontiers in Pharmacology, 6517 : .
0

Citations

0

Downloads

23

Views